Cancer Research Institute Ghent Belgium

Center for Medical Genetics Ghent University Hospital Belgium

Department of Clinical Chemistry Microbiology and Immunology Ghent University Belgium

Department of Genetics University Hospital of Robert Debré and Paris Diderot University Paris France

Department of Pediatric Hematology Oncology and Stem Cell Transplantation Ghent University Hospital Belgium

Department of Pediatric Hematology Oncology Charles University and University Hospital Motol Prague Czech Republic

Department of Pediatrics Aarhus University Hospital Skejby Aarhus Denmark

Department of Women and Child Health University of Padova Italy

Division of Pediatric Hematology and Oncology Department of Pediatrics and Adolescent Medicine University of Freiburg Germany

Dutch Childhood Oncology Group The Hague the Netherlands

Princess Máxima Center for Pediatric Oncology Utrecht the Netherlands

Zobrazit více v PubMed

Niemeyer CM. RAS diseases in children. Haematologica. 2014; 99(11):1653–1662. PubMed PMC

Locatelli F, Niemeyer CM. How I treat juvenile myelomonocytic leukemia. Blood. 2015; 125(7):1083–1090. PubMed

Stieglitz E, Taylor-Weiner AN, Chang TY, et al. The genomic landscape of juvenile myelomonocytic leukemia. Nat Genet. 2015; 47(11):1326–1333. PubMed PMC

Caye A, Strullu M, Guidez F, et al. Juvenile myelomonocytic leukemia displays mutations in components of the RAS pathway and the PRC2 network. Nat Genet. 2015; 47(11):1334–1340. PubMed

Helsmoortel HH, Bresolin S, Lammens T, et al. LIN28B overexpression defines a novel fetal-like subgroup of juvenile myelomonocytic leukemia. Blood. 2016; 127(9):1163–1172. PubMed

Lipka DB, Witte T, Toth R, et al. RAS-pathway mutation patterns define epigenetic subclasses in juvenile myelomonocytic leukemia. Nature Commun. 2017; 8(1):2126. PubMed PMC

Stieglitz E, Mazor T, Olshen AB, et al. Genome-wide DNA methylation is predictive of outcome in juvenile myelomonocytic leukemia. Nature Commun. 2017; 8(1):2127. PubMed PMC

Volders PJ, Helsens K, Wang X, et al. LNCipedia: a database for annotated human lncRNA transcript sequences and structures. Nucleic Acids Res. 2013; 41(Database issue):D246–251. PubMed PMC

Bhan A, Soleimani M, Mandal SS. Long Noncoding RNA and Cancer: A New Paradigm. Cancer Res. 2017;77(15):3965–3981. PubMed PMC

Schwarzer A, Emmrich S, Schmidt F, et al. The non-coding RNA landscape of human hematopoiesis and leukemia. Nature Commun. 2017; 8(1):218. PubMed PMC

Subramanian A, Tamayo P, Mootha VK, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA. 2005; 102(43):15545–15550. PubMed PMC

Garzon R, Volinia S, Papaioannou D, et al. Expression and prognostic impact of lncRNAs in acute myeloid leukemia. Proc Natl Acad Sci USA. 2014;111(52):18679–18684. PubMed PMC

Addelman S. The Generalized Randomized Block Design. Am Stat. 1969; 23(4):35–36.

Lee S, Seo HH, Lee CY, et al. Human Long Noncoding RNA Regulation of Stem Cell Potency and Differentiation. Stem Cells Int. 2017;2017:6374504. PubMed PMC

Bresolin S, Zecca M, Flotho C, et al. Gene expression-based classification as an independent predictor of clinical outcome in juvenile myelomonocytic leukemia. J Clin Oncol. 2010; 28(11):1919–1927. PubMed

Long non-coding RNAs as novel therapeutic targets in juvenile myelomonocytic leukemia

CircRNAs Dysregulated in Juvenile Myelomonocytic Leukemia: CircMCTP1 Stands Out